Strategic white matter tracts for processing speed deficits in age-related small vessel disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 30, 2013
- Accepted in final form January 21, 2014
- First Published May 2, 2014.
Article Versions
- Previous version (May 2, 2014 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Marco Duering, MD*,
- Benno Gesierich, PhD*,
- Stephan Seiler, MD,
- Lukas Pirpamer,
- Mariya Gonik, PhD,
- Edith Hofer, PhD,
- Eric Jouvent, MD, PhD,
- Edouard Duchesnay, PhD,
- Hugues Chabriat, MD, PhD,
- Stefan Ropele, PhD,
- Reinhold Schmidt, MD and
- Martin Dichgans, MD
- Marco Duering, MD*,
NONE
NONE
travel expenses for lectures from the United Leukodystrophy Foundation, the European Stroke Conference and Kenes International
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Vascular Dementia Research Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Benno Gesierich, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stephan Seiler, MD,
NONE
NONE
(1) Lundbeck, travel funding
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Rotary Club Innsbruck
NONE
NONE
NONE
NONE
NONE
NONE
- Lukas Pirpamer,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
as reported in the manuscript: This work was supported by the Vascular Dementia Research Foundation, the German Center for Neurodegenerative iseases (DZNE), an FP6 ERA-NET NEURON grant (01 EW1207),3 Fondation Leducq (Transatlantic Network of Excellence on he Pathogenesis of Small Vessel Disease of the Brain) and by the Austrian Science Fund projects P20103 and I904.
NONE
NONE
NONE
NONE
NONE
NONE
- Mariya Gonik, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Edith Hofer, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eric Jouvent, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Edouard Duchesnay, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hugues Chabriat, MD, PhD,
Lundbeck, Janssen
NONE
NONE
Cerebrovascular disease (member of the editorial board)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Ropele, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Reinhold Schmidt, MD and
Rivastigmin Patch, 2010, Novartis JSW Life Sciences 2010, Advisory Board for Dementia Trial Axon Neuroscience 2013
NONE
Received travel expenses and/or honoraria for lectures from Pfizer (2004-2010), Novartis (2003-2010), Merz Austria (2005-2010) and Lundbeck (2004-2009) and for educational activity from Takeda 2010
Editoral board member of Clinical Neurology and Neurosurgery 2004-currently
NONE
NONE
Pfizer 2004-2010,lectures Novartis 2003-2010, lectures Merz Austria 2005-2010, lectures Lundbeck 2004-2009, lectures Takeda, 2010, teaching course
QPS, Austria Axon Neuroscience
NONE
NONE
NONE
NONE
Austrian Science Fund projects P20103 and I904
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martin Dichgans, MD
NONE
NONE
(1) Bayer Vital, travel expenses and honoraria for lectures, (2) Boehringer Ingelheim Pharma, travel expenses and honoraria for lectures, (3) Heel, travel expenses and honoraria for lectures, (4) Bristol-Meyer Squibb, travel expenses and honoraria for lectures, (5) Lundeck, travel expenses and honoraria for lectures, (6) Sanofi-Aventis, travel expenses and honoraria for lectures, (7) Shire, travel expenses and honoraria for lectures, (8) German Research Foundation (DFG), research support, (9) Vascular Dementia Research Foundation, research support, (10) Corona Foundation, research support, (11) Jackst�dt Foundation, research support.
(1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor
NONE
NONE
NONE
(1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol-Meyer Squibb, (4) Heel
NONE
NONE
NONE
NONE
(1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15
NONE
(1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackst�dt Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the Institute for Stroke and Dementia Research (M. Duering, B.G., M.G., M. Dichgans), Klinikum der Universität München, Munich, Germany; the Department of Neurology (S.S., L.P., E.H., S.R., R.S.), Medical University of Graz; the Institute for Medical Informatics, Statistics and Documentation (E.H.), Graz, Austria; the Department of Neurology (E.J., H.C.), CHU Lariboisière, Assistance Publique des Hôpitaux de Paris; Neurospin (E.D.), CEA Saclay, Gif sur Yvette, France; the German Center for Neurodegenerative Diseases (DZNE, Munich) (M. Dichgans); and Munich Cluster for Systems Neurology (SyNergy) (M. Dichgans), Munich, Germany.
- Correspondence to Dr. Dichgans: martin.dichgans{at}med.uni-muenchen.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Gray and white matter changes linking cerebral small vessel disease to gait disturbancesYeo Jin Kim, Hun Ki Kwon, Jong Min Lee et al.Neurology, March 02, 2016 -
Editorial
Understanding brain function through small vessel diseaseWhat zebras can teach us about horsesSudha Seshadri, Frank-Erik de Leeuw et al.Neurology, May 02, 2014 -
Article
Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel DiseaseMarek J. Konieczny, Anna Dewenter, Annemieke ter Telgte et al.Neurology, November 16, 2020 -
Article
Vascular and dopaminergic contributors to mild parkinsonian signs in older adultsAndrea L. Rosso, Nicolaas I. Bohnen, Lenore J. Launer et al.Neurology, December 15, 2017